BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 20408053)

  • 1. Assessment of cell-free DNA with microvascular complication of type II diabetes mellitus, using PCR and ELISA.
    El Tarhouny SA; Hadhoud KM; Ebrahem MM; Al Azizi NM
    Nucleosides Nucleotides Nucleic Acids; 2010 Mar; 29(3):228-36. PubMed ID: 20408053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients].
    Moleda P; Majkowska L; Safranow K; Adler G; Goracy I
    Przegl Lek; 2007; 64(3):134-9. PubMed ID: 17941464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The relationship of methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in type 2 diabetes mellitus patients with diabetic retinopathy].
    Sun J; Xu Y; Zhu Y; Lu H; Deng H; Fan Y; Sun S; Zhang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):131-4. PubMed ID: 12673582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus.
    Zumbach M; Hofmann M; Borcea V; Luther T; Kotzsch M; Müller M; Hergesell O; Andrassy K; Ritz E; Ziegler R; Wahl P; Nawroth PP
    Exp Clin Endocrinol Diabetes; 1997; 105(4):206-12. PubMed ID: 9285207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mean platelet volume in patients with type 2 diabetes mellitus.
    Papanas N; Symeonidis G; Maltezos E; Mavridis G; Karavageli E; Vosnakidis T; Lakasas G
    Platelets; 2004 Dec; 15(8):475-8. PubMed ID: 15763888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of free L-carnitine levels in type II diabetic women with and without complications.
    Poorabbas A; Fallah F; Bagdadchi J; Mahdavi R; Aliasgarzadeh A; Asadi Y; Koushavar H; Vahed Jabbari M
    Eur J Clin Nutr; 2007 Jul; 61(7):892-5. PubMed ID: 17311064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in metallothionein-1 and -2 genes associated with the risk of type 2 diabetes mellitus and its complications.
    Yang L; Li H; Yu T; Zhao H; Cherian MG; Cai L; Liu Y
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E987-92. PubMed ID: 18349110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between plasma homocysteine and chronic complications in type 2 diabetes mellitus].
    Li WP; Li W; Yang T
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):349-50. PubMed ID: 15772011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunochemical quantification of crossline as a fluorescent advanced glycation endproduct in erythrocyte membrane proteins from diabetic patients with or without retinopathy.
    Yamaguchi M; Nakamura N; Nakano K; Kitagawa Y; Shigeta H; Hasegawa G; Ienaga K; Nakamura K; Nakazawa Y; Fukui I; Obayashi H; Kondo M
    Diabet Med; 1998 Jun; 15(6):458-62. PubMed ID: 9632118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications.
    Gerrits EG; Lutgers HL; Kleefstra N; Graaff R; Groenier KH; Smit AJ; Gans RO; Bilo HJ
    Diabetes Care; 2008 Mar; 31(3):517-21. PubMed ID: 18039805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severity of diabetic microvascular complications is associated with a low soluble RAGE level.
    Grossin N; Wautier MP; Meas T; Guillausseau PJ; Massin P; Wautier JL
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):392-5. PubMed ID: 18701333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldose reductase gene polymorphisms and susceptibility to microvascular complications in Type 2 diabetes.
    Sivenius K; Niskanen L; Voutilainen-Kaunisto R; Laakso M; Uusitupa M
    Diabet Med; 2004 Dec; 21(12):1325-33. PubMed ID: 15569136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
    Zhu H; Shi CH
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus.
    Funk M; Endler G; Exner M; Marculescu R; Endler L; Abrahamian H; Mauler H; Grimm A; Raith M; Mannhalter C; Prager R; Irsigler K; Wagner OF
    Wien Klin Wochenschr; 2005 Oct; 117(19-20):707-10. PubMed ID: 16416371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the VEGF 936 C/T polymorphism in diabetic microvascular complications in type 2 diabetic patients.
    Kim HW; Ko GJ; Kang YS; Lee MH; Song HK; Kim HK; Cha DR
    Nephrology (Carlton); 2009 Oct; 14(7):681-8. PubMed ID: 19796028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of plasma alpha-2-macroglobulin levels in type 2 diabetic subjects with microalbuminuria.
    Ahmad J; Singh M; Saleemuddin M
    J Assoc Physicians India; 2001 Nov; 49():1062-5. PubMed ID: 11868856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between polymorphisms 804C/A and 252A/G of lymphotoxin-alpha gene and -308G/A of tumor necrosis factor alpha gene and diabetic retinopathy in Japanese patients with type 2 diabetes mellitus.
    Yoshioka K; Yoshida T; Takakura Y; Umekawa T; Kogure A; Toda H; Yoshikawa T
    Metabolism; 2006 Oct; 55(10):1406-10. PubMed ID: 16979413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of angiotensin-converting enzyme gene polymorphism in Turkish type 2 diabetic patients.
    Degirmenci I; Kebapci N; Basaran A; Efe B; Gunes HV; Akalin A; Kurt H; Urhan M; Demirustu C
    Int J Clin Pract; 2005 Oct; 59(10):1137-42. PubMed ID: 16178979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma lipids and lipoproteins in type II diabetic Nigerians with retinopathy.
    Erasmus RT; Alanamu RA; Bojuwoye B
    Trop Geogr Med; 1991; 43(1-2):55-8. PubMed ID: 1750130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.
    Abdul-Ghani M; Nawaf G; Nawaf F; Itzhak B; Minuchin O; Vardi P
    Isr Med Assoc J; 2006 Jun; 8(6):378-82. PubMed ID: 16833164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.